SIBN insider sells 400 shares under 10b5-1 plan | Form 4
SI-BONE, Inc. (SIBN) reported an insider transaction by its SVP, Ops & Adm/Chief Legal Officer.
Rhea-AI Filing Summary
SI-BONE, Inc. (SIBN) reported an insider transaction by its SVP, Ops & Adm/Chief Legal Officer. On 11/24/2025, the officer sold 400 shares of common stock at $20 per share, reported with transaction code "S" for a sale. The filing notes that this trade was made under a Rule 10b5-1 trading plan dated June 13, 2025, which is a pre-arranged plan for selling shares.
After this transaction, the reporting person beneficially owned 251,496 shares of SI-BONE common stock. This total includes 125,823 shares issuable upon settlement of restricted stock units, where each unit represents the right to receive one share of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 400 | $20.00 | $8K |
Footnotes (2)
- F1. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated June 13th, 2025.
- F2. Includes 125,823 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.
FAQ
What insider transaction did SI-BONE (SIBN) disclose in this Form 4?
Who is the reporting person in the SI-BONE (SIBN) Form 4 and what is their role?
Was the SIBN insider sale made under a Rule 10b5-1 trading plan?
How many restricted stock units (RSUs) are included in the insider’s SIBN holdings?
Is this SI-BONE (SIBN) Form 4 filed for one or multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.